Nature Medicine | Spoonful of Medicine

Malaria vaccine holds strong in trial

Researchers reported today that the most advanced experimental malaria vaccine developed to date, GlaxoSmithKline’s Mosquirix, provides African children with long-lasting protection against the infectious disease. 

BACK TO ARTICLE

Tell a Friend

Please ensure that your friend is content to receive an email from us with a link to the article. Select the following link to view our Privacy Policy.

BACK TO ARTICLE